BetaKine recombinant TGF-beta-2: NIH began a Phase I open-label trial

Celtrix Pharmaceuticals Inc. (CTRX), Santa Clara, Calif. Product: BetaKine recombinant TGF-beta-2 Indication: Multiple sclerosis Status: NIH began a Phase I open-label trial in nine patients with act...